imipramine

Article

imipramine is a recurring brand in the Astral Codex Ten archive, appearing 3 times across 3 issues between March 31, 2021 and December 22, 2021. The archive places it in contexts such as “maximum doses of those medications are 60 mg and 80 mg … convert these to mg imipramine equivalents”; “imipramine, nortriptyline, and clomipramine are all reasonable choices”; “100 mg imipramine-equivalent dose”. It most often appears alongside FDA, escitalopram, SSRI.

Metadata

  • Category: Brands
  • Mention count: 3
  • Issue count: 3
  • First seen: March 31, 2021
  • Last seen: December 22, 2021

Appears In

Source Context

Recovered passages from the original issue text. When the raw archive preserved outbound links inside the source passage, they are listed directly under the quote.

March 31, 2021 · Original source
16.7 mg Lexapro equals 20 mg of paroxetine (Paxil) or fluoxetine (Prozac). But the maximum approved doses of those medications are 60 mg and 80 mg, respectively. If we convert these to mg imipramine equivalents like the study above uses, Prozac maxes out at 400, Paxil at 300, and Lexapro at 120. So Lexapro has a very low maximum dose compared to other similar antidepressants. Why?
They find antidepressants are most effective (the first graph, marked "response") at doses equivalent to 30 mg of fluoxetine (aka Prozac; 1 fluoxetine-equivalent = 5 of the imipramine-equivalents the other study uses). If that were true, the most effective dose of every SSRI would be:
May 25, 2021 · Original source
Amitriptyline is my preferred tricyclic, a large and sprawling class of older antidepressants. Other people might have different preferred tricyclics; imipramine, nortriptyline, and clomipramine are all reasonable choices in different situations. It can also cause tiredness and weight gain, and has a small risk of heart problems in vulnerable/older people. On the other hand, in Andrea Cipriani’s massive meta-analysis of antidepressant efficacy, it ranked first out of 21 different drugs (my third- tier suggestions weren’t studied, because the researchers were cowards).
December 22, 2021 · Original source
For some reason the same experts who don’t mind prescribing SSRIs when people have mild depression freak out about prescribing them when they’re the only evidence-based oral medication for a deadly global pandemic. “What about SSRI withdrawal?”, they ask. After a ten day course? On 100 mg imipramine-equivalent dose? Minimal. “What about long QT syndrome?” The VA system took 35,000 high-risk older patients off of an unusually-likely-to-cause-QT-syndrome SSRI in 2011, and were unable to find any evidence that this prevented even a single case of the syndrome, let alone any negative outcome!